Share This Page
Drug Price Trends for NDC 00113-0087
✉ Email this page to a colleague
Average Pharmacy Cost for 00113-0087
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| GS ANTI-DIARRHEAL-ANTIGAS CPLT | 00113-0087-62 | 0.30728 | EACH | 2025-12-17 |
| GS ANTI-DIARRHEAL-ANTIGAS CPLT | 00113-0087-53 | 0.30728 | EACH | 2025-12-17 |
| GS ANTI-DIARRHEAL-ANTIGAS CPLT | 00113-0087-62 | 0.30323 | EACH | 2025-11-19 |
| GS ANTI-DIARRHEAL-ANTIGAS CPLT | 00113-0087-53 | 0.30323 | EACH | 2025-11-19 |
| GS ANTI-DIARRHEAL-ANTIGAS CPLT | 00113-0087-62 | 0.29900 | EACH | 2025-10-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00113-0087
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 00113-0087
Introduction
NDC 00113-0087 corresponds to a specific pharmaceutical product registered with the Food and Drug Administration (FDA). Precise identification requires referencing the product name, formulation, and therapeutic class, which typically influence market dynamics and pricing strategies. For this analysis, precision in understanding the product's therapeutic use, current market trends, competitive landscape, and regulatory environment is critical in formulating accurate market projections and pricing forecasts.
This report provides a comprehensive analysis of the current market landscape for NDC 00113-0087, evaluates future pricing trajectories, and discusses strategic considerations relevant for stakeholders, including pharmaceutical companies, investors, and healthcare providers.
Product Overview and Regulatory Context
NDC 00113-0087 refers to [Insert specific medication name], manufactured by [Manufacturer Name]. It belongs to the [Therapeutic Class]—used to [indicate primary indication, e.g., treating type 2 diabetes, oncology, autoimmune disorders]. The product entered the market in [Year] and has since established a foothold in the [region, e.g., U.S., global markets].
Regulatory milestones include FDA approval in [Year], with subsequent indications expansion or formulation modifications. The product benefits from [patent protection, exclusivity periods, or biosimilar competition] influencing initial pricing and market entry strategies.
Market Landscape
Current Market Size
The existing market size for [drug class or indication] is estimated at $[X] billion, with a compound annual growth rate (CAGR) of [Y]%, reflecting [growth drivers—e.g., increased disease prevalence, unmet medical needs, treatment guideline updates]. The particular focus for NDC 00113-0087 encompasses approximately [relevant patient population size] in the U.S., aligned with [specific demographic or clinical criteria].
Competitor Analysis
The competitive environment comprises both brand-name pharmaceuticals and biosimilars or generics. Key competitors include [List major competitors, e.g., Drug A, Drug B], with market shares of [X]% and [Y]%, respectively. The incumbent products differ in efficacy profiles, administration routes, and safety profiles, influencing the positioning of NDC 00113-0087.
Emerging competition from biosimilars or new therapeutic options could disrupt market share distribution in the coming years. Patent expirations or regulatory challenges might open avenues for new entrants, affecting pricing and revenue streams.
Regulatory and Pricing Environment
The U.S. healthcare landscape signals increasing pressure for cost containment, influencing pharmaceutical pricing strategies. Initiatives like value-based pricing, increased transparency, and incluions in formularies directly impact drug prices.
Medicare and Medicaid reimbursement policies, along with insurer negotiations, tend to cap patient access and influence pharmaceutical revenue potential. [Reference: CMS reimbursement policies or state-specific regulations].
Price Dynamics and Projections
Historical Pricing Trends
Since market entry, the average wholesale price (AWP) for similar drugs has experienced fluctuations, often fluctuating based on patent protection, market competition, and changes in treatment guidelines. For NDC 00113-0087, initial launch prices ranged from $[a] to $[b] per unit (dose or treatment course), with subsequent adjustments driven by market dynamics.
Forecasting Future Prices
Factors influencing future pricing include:
- Patent and exclusivity status: The expiration of patent protection will likely induce price erosion due to competition from generics or biosimilars.
- Market penetration and adoption: Prescriber preference shifts, evidence of clinical superiority or cost-effectiveness will impact the volume and pricing strategies.
- Regulatory approvals: Expansion to new indications may increase the drug’s value and pricing power.
- Healthcare policy changes: Reimbursements and caps on drug prices could exert downward pressure.
Based on these factors, [consultation of market models or expert opinions], the projected price trajectory suggests:
| Year | Price per unit (USD) | Notes |
|---|---|---|
| 2023 | $X | Current market price |
| 2024 | $X+Y% | Slight increase due to inflation or demand |
| 2025 | $X+(Y+Z)% | Price stabilization anticipated post-patent expiry |
| 2030 | $A | Potential drop of [Z]% with biosimilar entry |
Price Sensitivity and Affordability
The drug’s affordability influences patient access, especially with a high-cost profile typical of biologics or novel molecular entities. Payers may negotiate discounts or implement utilization controls, impacting revenue and market share.
Regional Price Variations
Pricing in international markets varies due to regulatory, economic, and healthcare infrastructure differences. Developed countries tend to maintain higher prices, whereas emerging markets may see steep discounts to improve access.
Strategic Implications
Pricing strategies should incorporate:
- Differentiation through efficacy and safety profiles to justify premium pricing.
- Engagement with payers to secure formulary placements and favorable reimbursement terms.
- Optimization of manufacturing and supply chain efficiencies to sustain margins amid pricing pressures.
- Monitoring patent landscapes to proactively plan for biosimilar or generic competition.
- Participation in value-based agreements linking reimbursement to clinical outcomes.
Conclusion
The market trajectory of NDC 00113-0087 presents both opportunities and challenges. The drug’s current positioning within a competitive landscape suggests stable revenue streams, contingent on strategic pricing and market access initiatives. Anticipated patent expirations and evolving healthcare policies forecast potential price reductions, necessitating adaptive strategic planning.
Stakeholders should continuously monitor regulatory developments, competitor activities, and payer policies to optimize pricing and market penetration strategies, ensuring sustainable growth in a dynamic pharmaceutical environment.
Key Takeaways
- Market Size & Growth: The [drug class/indication] market is currently valued at approximately $[X] billion, with a CAGR of [Y]%, driven by increasing disease prevalence and treatment adoption.
- Competitive Landscape: The market is crowded with established brands and emerging biosimilars, placing downward pressure on prices over time, especially post-patent expiry.
- Pricing Trends: The initial market prices ranged from $[a] to $[b] per unit; projections indicate a gradual decline following patent expiration, with potential for stabilization due to differentiation.
- Regulatory & Policy Impact: Healthcare reforms emphasizing cost containment could influence reimbursement structures, requiring negotiation and strategic engagement with payers.
- Strategic Outlook: Success relies on demonstrating clinical value, securing formulary acceptance, and proactive patent and competition management.
FAQs
1. What factors most significantly influence the pricing of NDC 00113-0087?
Pricing depends on patent status, clinical efficacy, safety profile, market competition, healthcare policies, and payer negotiations.
2. How will patent expiration affect the drug's market share and price?
Patent expiry typically leads to generic or biosimilar entry, increasing competition, which exerts downward pressure on price and can reduce market share unless offset by value-based differentiation.
3. What role do biosimilars play in shaping future projections for this drug?
Biosimilars can significantly reduce prices and expand access, influencing revenue streams and compelling existing manufacturers to innovate or differentiate.
4. How do healthcare policies impact the drug’s reimbursement prospects?
Policies aimed at reducing healthcare costs may negotiate lower reimbursement rates or impose utilization restrictions, influencing profitability.
5. What strategies can pharmaceutical companies adopt to maintain market relevance post-patent expiry?
Innovative reformulations, expanding indications, patient support programs, and value-based agreements help sustain competitive advantage.
References
- [Insert relevant source, e.g., FDA drug database, market research reports, government health agency publications]
- [Insert insights from industry reports or expert analyses]
- [Include regulatory policy documents applying to drug pricing and reimbursement]
Note: The specific figures and product details should be updated once detailed product data and market intelligence are available.
More… ↓
